Results 181 to 190 of about 12,242 (218)
Co-circulation of multiple arboviruses in acute febrile patients in Yunnan, China, identified by metagenomic sequencing. [PDF]
J Clin MicrobiolChen M +12 more
europepmc +1 more source
Immunopathological mechanisms and targeted intervention strategies for chronic chikungunya arthritis: from viral persistence to autoimmunity. [PDF]
Front ImmunolZeng L +10 more
europepmc +1 more source
Travel-Related Challenges of Chikungunya Virus and Vaccination Options. [PDF]
J Epidemiol Glob HealthBarry M +3 more
europepmc +1 more source
Predicting the global risk of chikungunya virus under climate change using ensemble species distribution models. [PDF]
Front Cell Infect MicrobiolZhang Q +9 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Proteomics, 2014
Chikungunya virus (CHIKV) is an arthropod-borne, positive-sense, single-stranded RNA virus belonging to genus Alphavirus and family Togaviridae. The clinical manifestations developed upon CHIKV-infection include fever, myositis, arthralgia and maculopapular rash. Thus, the re-emergence of CHIKV has posed serious health threats worldwide.
Justin Jang Hann Chu, Eng Lee Tan
exaly +3 more sources
Chikungunya virus (CHIKV) is an arthropod-borne, positive-sense, single-stranded RNA virus belonging to genus Alphavirus and family Togaviridae. The clinical manifestations developed upon CHIKV-infection include fever, myositis, arthralgia and maculopapular rash. Thus, the re-emergence of CHIKV has posed serious health threats worldwide.
Justin Jang Hann Chu, Eng Lee Tan
exaly +3 more sources
Journal of Immunological Methods
Chikungunya fever (CHIKF) is a viral illness transmitted by mosquitoes, caused by the chikungunya virus (CHIKV), which has led to millions of infections globally. Antibodies against CHIKV serve as essential tools for research on this virus. In this study, we designed peptides corresponding to the E1, E2, E3, and capsid proteins of CHIKV to immunize New
Leiliang Zhang
exaly +3 more sources
Chikungunya fever (CHIKF) is a viral illness transmitted by mosquitoes, caused by the chikungunya virus (CHIKV), which has led to millions of infections globally. Antibodies against CHIKV serve as essential tools for research on this virus. In this study, we designed peptides corresponding to the E1, E2, E3, and capsid proteins of CHIKV to immunize New
Leiliang Zhang
exaly +3 more sources
Antiviral Research, 2014
The global emergence of Chikungunya virus (CHIKV) infection is alarming and currently there is no licensed vaccine or antiviral treatment available to mitigate this disease. CHIKV infection typically results in high viral load with an outcome of high fever, skin rashes, muscle pain, and sequelae of prolonged arthritis, which occurs in >90% of the ...
Andres Merits +2 more
exaly +3 more sources
The global emergence of Chikungunya virus (CHIKV) infection is alarming and currently there is no licensed vaccine or antiviral treatment available to mitigate this disease. CHIKV infection typically results in high viral load with an outcome of high fever, skin rashes, muscle pain, and sequelae of prolonged arthritis, which occurs in >90% of the ...
Andres Merits +2 more
exaly +3 more sources
A recombinant CHIKV-NLuc virus identifies chondrocytes as target of Chikungunya virus in a immunocompetent mouse model [PDF]
Abstract First isolated in 1953 in Tanzania, the arthritogenic Chikungunya virus (CHIKV) re-emerged globally in 2005, leading to widespread outbreaks. Unlike other arboviruses, CHIKV predominantly induces symptomatic infections (72-96%), marked by fever, myalgia, polyarthralgia, and rash.
Legros, Vincent +9 more
openaire +2 more sources